0001193125-20-275431.txt : 20201127 0001193125-20-275431.hdr.sgml : 20201127 20201023160259 ACCESSION NUMBER: 0001193125-20-275431 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20201023 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Galecto Inc. CENTRAL INDEX KEY: 0001800315 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 371957007 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: GALECTO BIOTECH AB STREET 2: OLE MAALOES VEJ3 CITY: COPENHAGEN STATE: G7 ZIP: DK-2200 BUSINESS PHONE: 45-70-70-52-10 MAIL ADDRESS: STREET 1: GALECTO BIOTECH AB STREET 2: OLE MAALOES VEJ3 CITY: COPENHAGEN STATE: G7 ZIP: DK-2200 FORMER COMPANY: FORMER CONFORMED NAME: Galecto Inc. DATE OF NAME CHANGE: 20200116 CORRESP 1 filename1.htm CORRESP

October 23, 2020

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

 

Attn:

Donald Field

Susan Block

Kristin Lochhead

Kate Tillan

 

Re:

Galecto, Inc. Registration Statement on Form S-1, as amended (Registration No. 333-249369)

Dear Mr. Field:

In connection with the above-referenced Registration Statement, as amended, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we hereby join in the request of Galecto, Inc. that the effective date of the Registration Statement, as amended, be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on October 27, 2020, or as soon thereafter as practicable.

Pursuant to Rule 460 under the Act, please be advised that we and the other prospective underwriters have distributed approximately 2,000 copies of the preliminary prospectus dated October 22, 2020 through the date hereof, to underwriters, dealers, institutions and others.

In connection with the preliminary prospectus distribution for the above-referenced issue, the prospective underwriters have confirmed that they are complying with the 48-hour requirement in Rule 15c2-8(b) under the Securities Exchange Act of 1934, as amended.

Very truly yours,

BOFA SECURITIES, INC.

SVB LEERINK LLC

CREDIT SUISSE SECURITIES (USA) LLC

As Representatives of the several underwriters

[SIGNATURE PAGE FOLLOWS]

BOFA SECURITIES, INC.
By:  

/s/ Michele A.H. Allong

 

Name: Michele A.H. Allong

 

Title: Authorized Signatory

SVB LEERINK LLC
By:  

/s/ Gabriel Cavazos

  Name: Gabriel Cavazos
  Title: Managing Director
CREDIT SUISSE SECURITIES (USA) LLC
By:  

/s/ Rebecca Kotkin

  Name: Rebecca Kotkin
  Title: Director

As representatives of the several underwriters.

 

[Signature Page to Acceleration Request Letter]